LILLIE JAMES WOODRUFF (Chief Scientific Officer) sold 1.5% of their position (4.51K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $122.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/17/2026ACC: 0001728746-26-000006
Officer· Chief Scientific Officer
Since Feb 2026
-4.51K
Net shares
Net seller
$122.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.51K disposed
Non-Derivative Transactions3
Voting Common Stock
Direct
Shares
−1.73K
Price / share
$26.82
Trade value
$46.40K
% of position
0.6%
4/15/2026
299.67K→297.94K
Voting Common Stock
Direct
Shares
−686.00
Price / share
$27.01
Trade value
$18.53K
% of position
0.2%
4/16/2026
297.94K→297.25K
Voting Common Stock
Direct
Shares
−2.10K
Price / share
$27.49
Trade value
$57.65K
% of position
0.7%
4/16/2026
297.25K→295.16K
Total
Net shares
−4.51K
Net value
-$122.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 4/15/2026 | S · Sale | −1.73K | $26.82 | $46.40K | 0.6% | 299.67K | 297.94K |
| Voting Common Stock Direct | 4/16/2026 | S · Sale | −686.00 | $27.01 | $18.53K | 0.2% | 297.94K | 297.25K |
| Voting Common Stock Direct | 4/16/2026 | S · Sale | −2.10K | $27.49 | $57.65K | 0.7% | 297.25K | 295.16K |
| Total | −4.51K | -$122.57K | ||||||
Derivative Transactions0
No derivative transactions reported